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Objective: To assess the impact of a long-term exercise pro-
gramme vs usual care on perceived health status, functional 
capacity and depression in patients with fibromyalgia.
Design: Randomized controlled trial.
Subjects: Forty-two women with fibromyalgia were allocat-
ed randomly to 1 of 2 groups: an experimental group that 
carried out aerobic, strength and flexibility exercises for 24 
weeks and a usual care control group.
Methods: Health status and functional capacity were evalu-
ated using the Fibromyalgia Impact Questionnaire and the 
Short Form Health Survey 36. Depression was evaluated 
with the Beck Depression Inventory.
Results: Significant improvements were observed in health 
status and functional capacity for the exercise group over the 
control group. The magnitude of the effect size of these im-
provements, expressed as Cohen’s d, was medium. The effect 
size (95% confidence interval) for the Fibromyalgia Impact 
Questionnaire was 0.58 (–14.12, –2.35), for the Short Form 
Health Survey 36. global score 0.54 (1.28, 14.52), and in the 
mental health domain of the Short Form Health Survey 36. 
0.51 (1.20, 16.26). There was a large effect size in vitality. 
All the aforementioned improvements can be considered as 
clinically important changes.
Conclusion: Results confirm that a long-term combination of 
aerobic exercise, strengthening and flexibility improves psy-
chological health status and health-related quality of life in 
patients with fibromyalgia.
Key words: physical activity; fibromyalgia; exercise; health-
related quality of life. 
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INTRODUCTION
Fibromyalgia (FM) is a contentious clinical syndrome, char-
acterized by diffuse musculoskeletal pain and reduced pain 
threshold, particularly at defined “tender points”. The condition 
is often accompanied by generalized fatigue, sleep distur-
bance, and psychological distress (1). Patients with FM have 
decreased functional ability, poorer health status and decreased 
quality of life (QoL) compared with healthy subjects or those 
with other chronic diseases (2, 3). The pathogenesis of FM is 
not entirely understood, although the current theory is that FM 
is the result of central nervous system dysfunction, resulting 
in central sensitization and pain amplification (4). In addition, 
psychological factors may be implicated in the development 
and maintenance of FM (5).
Although there are several treatment options available, 
the optimal management for FM remains elusive. Clinical 
guidelines recommend a broad range of pharmacological and 
non-pharmacological therapies (6, 7), but the impact of such 
treatments on QoL and function is still debated (6). Neverthe-
less, there is evidence that physical exercise can have an impact 
on the clinical presentation of patients with FM. Exercise has 
been demonstrated to be effective in improving patients’ health-
related QoL, general function, psychological well-being, and 
other symptoms, such as anxiety and depression (8–13). Indeed, 
exercise is considered to be the main non-pharmacological strat-
egy in the management of FM. However, many of the exercise 
programmes used in clinical trials in FM are limited due to the 
short duration of the interventions (13–15), with some interven-
tions being as short as 3 weeks (16, 17).
There is clear evidence from the sports science literature that 
interventions aimed at improving aerobic capacity or muscle 
strength and endurance should be of at least 15–24 weeks’ dura-
tion in order to attain most of the possible effects (18), although 
a duration of 6 months (at least 24 weeks) is recommended to 
obtain additional health benefits (19). Furthermore, many of the 
interventions used in clinical trials in FM use only single exercise 
interventions that do not reflect clinical practice (20) or clinical 
guidelines, which recommend a range of exercise interventions 
in FM, including aerobic and strengthening exercises (6, 21). 
There is broad agreement in the literature about the need for 
long-term studies assessing the benefit of exercise for FM (21), 
especially concurrent strength and endurance training (22).
The aim of the current study was therefore to assess the 
effectiveness of a prolonged exercise programme (24 weeks), 
based on a combination of aerobic exercise, muscle strengthen-
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ing and flexibility exercises, on the psychological well-being 
and QoL of women with FM. 
METHods
Sample size calculation
sample size was estimated following the recommendations of 
McCrum-gardner (23) using Ps software (available from: http://
biostat.mc.vanderbilt.edu/wiki/Main/Powersamplesize). using a 
mean difference between the two groups of 14, which is considered 
the minimally clinical important difference (MCId) for the primary 
outcome measure, the Fibromyalgia Impact Questionnaire (FIQ) (24) 
and a standard deviation (sd) of 14 (25), gives a sample size of 17 per 
group. Allowing for an attrition rate of approximately 20% gives a total 
sample 42, providing 80% power at the 95% significance level. 
Participants
Inclusion criteria for study participants were: women, aged 18 to 65 
years, diagnosed with FM based on the America College of rheumatol-
ogy Criteria (1), and had to give written informed consent to participate 
in the study. Exclusion criteria were: any significant concomitant 
medical illness, such as inflammatory rheumatic diseases, respiratory 
or cardiovascular diseases that would prevent physical exercise, or 
severe psychiatric illness. Finally, those women with FM who had 
attended physical therapy or psychological therapy in the previous 3 
months were excluded from the study to avoid possible carry-over to 
the present trial. Participants were asked not to start a new course of 
medication during the course of the trial; they were allowed to continue 
with their current medication and use “rescue analgesic” as normal. 
Recruitment procedure
Participants were recruited from 3 local patient support groups in 
Seville, Spain, and screened for entry into the study from April 2007 
to January 2008 by one investigator (dg) who was blind to the rand-
omization sequence. Participants were interviewed by the examining 
physician using a standardized questionnaire to record sociodemo-
graphic characteristics and medication. 
A total of 53 women were eligible for entry into the study, 11 
participants were excluded due to co-morbidities, participation in 
another treatment, incompatible work, and 3 people declined to par-
ticipate. The 42 patients who met the inclusion criteria were allocated 
randomly to an experimental group that would receive an exercise 
programme (Ex, n = 21) and a usual care control group (uC, n = 21). 
randomization was based on a computer-generated random number 
table, and group allocation was conducted by LC, who was unaware 
of the randomization sequence, and was not involved in the day-to-
day running of the trial. The result of randomization was unknown 
until the participant accepted or declined to participate in the project. 
The randomization sequence was not disclosed to the researcher 
responsible for the day-to-day running of the trial (bs) until patients 
had completed their baseline assessments. Fig. 1 shows the flow of 
participants through the trial. The study was approved by the ethics 
committee of the University of Seville and conformed to the principles 
of the declaration of Helsinki. 
Outcome measures
Patients attended for initial assessment at the Physical Education and 
sport Laboratory, university of seville. At baseline (T1), demographic 
information, clinical details including medication and outcome ques-
tionnaire (perceived functional ability, QoL and psychological health 
status) were collected. Assessment of all outcomes was undertaken 
at baseline (before randomization) and after the 24-week interven-
tion (T2). For both groups the outcome assessor was blind to group 
allocation throughout. 
Primary outcome measure
The Fibromyalgia Impact Questionnaire (FIQ) was the primary out-
come measure. The FIQ is a self-administered questionnaire validated 
in spanish for its use in patients with FM (26). The FIQ measures 
physical functioning, work status, and overall well-being; it also 
contains 6 visual analogue scales for pain, sleep, fatigue, morning 
stiffness, anxiety, and depression. The range of the total score is 
0–80, where a higher score indicates a more negative impact of FM. 
bennett et al. (24) estimated the MCId for the FIQ based on the find-
ings from 3 clinical trials and a total of 2228 patients. These authors 
reported that a 14% change represented a clinically important change 
in total FIQ score. 
Secondary outcome measures
short Form Health survey 36 (sF-36). The spanish version of the 
sF-36 is a self-administered questionnaire for measuring health-
related QoL validated in spanish populations (27). It contains 36 
items grouped into 8 subscales: physical functioning, physical role, 
bodily pain, general health, vitality, social functioning, emotional 
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role, and mental health. The range of scores is between 0 and 100 in 
every subscale, where a higher score indicates better health-related 
QoL. Angst et al. (28) reported that, in rehabilitation interventions, 
effects larger than 12% of baseline score can be interpreted as the 
MCID for the SF-36. 
Beck Depression Inventory
The beck depression Inventory (bdI) contains 21 items that assess 
the cognitive, affective, and neurovegetative factors associated with 
depression. The score ranges from 0 to 63, where values greater than 
13 indicate presence of depression, and values greater than 21 indicate 
major depression (29). This instrument was also recommended for 
assessment of change in depression after exercise interventions in 
patients with a diagnosis of FM (21). dworkin et al. (30) reported that 
a change of 5 points on the bdI could be considered a reasonable esti-
mate of a clinically important change for patients with chronic pain. 
Interventions
The Ex group performed twice-weekly sessions of combined aerobic 
and muscle strength training exercises for 24 weeks. The exercise 
intervention was based on a 3-arm randomized controlled trial in 
which we investigated the feasibility of implementing our intervention 
combining different types of exercise in women with FM (31), but also 
on a recent study conducted by Valkeinen et al. (22) using concurrent 
strength and endurance training in low to moderate volume. The inter-
vention was further refined after discussions among the research group. 
The exercise intervention consisted of a 10-min warm-up including 
multi-joint movements, followed by 10–15 min of aerobic exercise at 
65–70% maximum heart rate (Hrmax: estimated as 220 – age of the 
participant), which was recommended for estimating Hrmax and for 
exercise prescriptions in women with FM (32). This intervention is in 
accordance with the American Pain society’s guidelines on FM, where 
it is recommended that patients perform moderately intense aerobic 
exercise at an intensity of 60–70% age-adjusted predicted Hrmax 2 or 
3 times per week (33). steady-state aerobic exercise was conducted in 
small groups in which patients performed continuous walking with arm 
movements and jogging. They were taught how to monitor their heart 
rate and adjust their activity to maintain the correct exercise intensity. 
Following aerobic exercise participants completed 15–20 min of mus-
cle strengthening exercises, which consisted of a circuit of 8 exercise 
stations. The 8 muscle groups targeted were: shoulders (deltoids and 
biceps), neck (trapezius), hip (gluteus and quadriceps) and back-chest-
torso (latissimus dorsi, pectoralis major, abdominals). Examples of 
exercises were: shoulder press, dumbbell press, shoulder elevation with 
resistance, biceps curl, dumbbell bent over row, squats, hip flexion and 
extension and standing hip abductor. At each station participants carried 
out 1 set of 8–10 repetitions (reps) with 1–3 kg weight. At the outset of 
the study resistance was deliberately set at a level that the patients could 
easily manage. Across the course of the study, however, resistance was 
increased gradually according to patient’s tolerance, as recommended 
by bircan et al. (13). Finally, participants performed a “cool-down” of 
10 min, which consisted of flexibility exercises (8 or 9 exercise stations, 
each station 1 set of 3 reps, holding the stretched position for 30 s). Hr 
was used to measure the intensity of exercise and was determined by 
using a HosANd® TM200 telemetric system (Hosand Technologies 
srl, Italy). This enabled participants to exercise within their estab-
lished exercise intensity thresholds (i.e. 60–75% Hrmax). Participants 
were instructed not to exert themselves and to perform exercises at a 
comfortable level for the first 5–6 weeks. After this, participants could 
increase exercise intensity within their own capacity using a heart rate 
monitor and individual knowledge of symptoms and level of overall 
fatigue as a guide. Classes were progressed to ensure that target heart 
rates were attained as subjects’ conditioning improved. For example, 
subjects were progressed from gentle arm and leg movements (week 
1) to intermittent jogging in the gymnasium (week 24). The uC group 
continued with their normal medical treatment for FM and continued 
their normal daily activities during the period of the intervention, which 
did not include any structured exercise. 
Statistical analysis
The normality of the data was evaluated by the kolmogorov-smirnov 
test. Chi squared tests were used to compare clinical categorical variables 
between both groups. To compare means, analysis of variance (ANoVA) 
2×2 (group×evaluation) was used for each outcome measure (FIQ, sF-36, 
bdI, physical function, physical role, bodily pain, general health, vitality, 
social functioning, role emotional and mental health). data were analysed 
from an intention-to-treat (ITT) perspective. For the purposes of analysis, 
participants remained in the groups to which they were randomly as-
signed. Those with missing data had the last recorded observation carried 
forward. This method for imputing missing values is conservative (i.e. 
it assumes no change), and therefore it is unlikely that differences will 
result purely on the basis of the method of imputation. 
In addition, effect sizes (Es) for each outcome measure were calculated. 
rosnow & rosenthal’s modified version of the Cohen’s d method for Es 
calculation was used, as recommended by Carville & Choy (34): 
d = M1 – M2/sd (pooled) 
sd (pooled) = √[(sd12 + SD22)/2] 
where d = Es, M1 = mean of the intervention group and M2 = mean 
of the control group, sd = standard deviation. The thresholds 
used for interpretation were as follows: values > 0.2 – 0.5 = small 
Es > 0.5 – 0.8 = medium Es, and > 0.8 = large Es. 
The results are expressed as the mean (sd) or 95% confidence 
interval and the significance level was determined at p < 0.05. Statis-
tical analysis was carried out using sPss for windows 15.0 (sPss, 
Chicago, IL, usA). 
rEsuLTs
The total number of patients who completed the trial was 38 
(Ex group n = 18 and uC group n = 20) (Fig. 1). Three patients 
in the Ex did not complete the trial. one patient dropped out 
because of concomitant illnesses (pneumonia), another two 
could not participate due to personal reasons. In the uC group, 
one patient was lost to follow-up and did not complete the 
trial. despite the relatively low attrition rate, the results are 
presented from an intention-to-treat perspective (n = 42). 
The rate of compliance with exercise sessions was high, with 
patients attending mean of 85% of the sessions. At baseline 
there were no significant between-group differences in any 
demographic variables (all p-values > 0.05; Table I). Partici-
pants were similar to other study populations (22), in that they 
were in their mid-50s, they were overweight, bordering on 
obese (bMI < 30 kg/m2 obese) and the vast majority were on 
medication for FM. 







Age, years, mean (sd) 55.48 (7.14) 56.15 (8.48)
weight, kg, mean (sd) 69.49 (11.32) 72.48 (11.97)
Height, m, mean (sd) 1.57 (0.08) 1.58 (0.07)
body mass index, kg/m2, mean, SD 28.19 (5.1) 29.03 (5.4)
Medication, %
None 18.75 15.79
Analgesic or NsAId 43.75 36.84
Antidepressant or SSRI 6.25 10.53
Combination analgesic + other 31.25 36.84
NsAId: non-steroidal anti-inflammatory drugs; ssrI: selective serotonin 
reuptake inhibitor; SD: standard deviation.
J Rehabil Med 43
524 B. Sañudo et al.
The mean (sd) outcome scores at baseline and after the 24-
week intervention period are shown in Table II. The exercise 
intervention resulted in significant improvements in the total 
FIQ score, total sF-36 score, and in some domains of the sF-36 
(physical function, general health, vitality and mental health). 
The Es (d) of these changes are noted to be medium for the 
total FIQ and total sF-36. The change in the vitality subscale 
of the sF-36 demonstrated a large Es, but only small effects 
are noted for the other variables. In considering the improve-
ments demonstrated in the intervention group, it is also worth 
stating that the magnitude of these changes demonstrate an 
important clinical impact on those with FM. The magnitude 
of the change in sF-36 total score was 20% (MICd 12%), 
and although the change in the FIQ was slightly less than the 
MCId, an improvement of 13% was noted. In addition, with 
regard to depression, there was no significant decrease in bdI 
scores; however, those in the intervention group reported an 
18% improvement. In contrast, patients in the uC group did 
not show an improvement in depression scores. 
DISCUSSION
The aim of this study was to evaluate the effectiveness of a 
combined programme of aerobic, strengthening and flexibility 
exercises, compared with usual care, in women with FM. The 
results show that a 24-week moderate-intensity combined 
exercise programme delivered twice a week, improved health-
 related QoL and function, although Es were modest the findings 
reinforce the importance of active exercise in FM. In contrast, 
patients receiving usual care did not show an improvement in 
any domain, indeed they experienced deterioration in some of 
the outcomes measured. 
The findings from the current study are similar to those 
reported by Häuser et al. (7). In a comprehensive systematic 
review and meta-analysis of randomized controlled trials 
evaluating exercise in FM (n = 28), these authors reported that 
aerobic and mixed exercise interventions improved (effect 
size; 95% confidence interval (CI)) QoL (–0.44; –0.60, –0.20), 
physical function (0.65; 0.38, 0.93) and depression (–0.44; 
–0.88, 0.01) in those with FM. 
There is little consensus in the literature over the most effec-
tive exercise protocol in FM; however, there is some evidence 
that exercise interventions of longer duration are most effec-
tive. Valim et al. (35), for example, compared aerobic fitness 
training and stretching exercises in patients with FM in relation 
to QoL. After 20 weeks’ intervention, aerobic exercise was 
superior to stretching in relation to the emotional aspects and 
mental health domains of sF-36, with Es even greater than 
those reported in this study (d = 0.61 and 0.90, respectively). 
In another study in which patients performed either deep-water 
running or land-based exercises for 15 weeks, again both the 
physical and psychological aspects of FM improved (10). 
when the duration of the exercise programme used in FM 
is reduced, the results are less clear. Cedraschi et al. (14) 
evaluated the efficacy of a mixed programme for patients 
with FM for 6 weeks, although the treatment group showed 
improvement in all of the sF-36 scores, results were not statis-
tically significant. The Es reported were all lower than those 
reported in the current study, although Cedraschi et al. (14) 
reported significant improvements for role physical (d = 0.24) 
and social functioning (d = 0.27). This can also be seen in the 
study conducted by redondo et al. (15), in which only the 
bodily pain domain showed a significant improvement after 8 
weeks of exercise treatment. This indicates that a short-term 
exercise programme may not be sufficient to induce significant 
improvements in health-related QoL in FM. redondo et al. (15) 
reported modest changes in Es for the sF-36; the Es changes 
for emotional aspects and vitality were d = 0.02 and d = 0.28, 
respectively, which may suggest that these domains are more 
influenced by the duration of the programme. 
strengthening exercise seems to have positive effects in 
those with FM; however, there are few previous studies that 
have used a similar strength-training programme as that used 
in the current study and have also used the FIQ as their primary 
outcome (36). kingsley et al. (36), after 12 weeks’ intervention, 
showed a slight improvement in FIQ scores, but this did not 
Table II. Effects of a 24-week combined exercise programme on functional capacity, perceived health status and depression in women with fibromyalgia 
syndrome compared with usual care (n = 42)
baseline 24 weeks 
Exercise Control
p-value 
between group Exercise Control
p-value 
between group d (95% CI)
FIQ (0–80) 63.1 (17.4) 61.6 (17.1) 0.761 54.9 (12.5) 64.5 (11.4) 0.027* 0.58 (–14.12, –2.35)
sF-36 (0–100) 38.9 (15.9) 37.3 (14.9) 0.758 46.8 (13.0) 35.9 (16.2) 0.043* 0.54 (1.28, 14.52)
Physical Function 50.0 (22.7) 44.6 (15.9) 0.422 56.8 (17.4) 45.2 (14.1) 0.043* 0.34 (.38, 13.56)
Physical role 13.5 (17.4) 19.8 (27.6) 0.451 21.3 (26.5) 19.4 (29.1) 0.848 0.35 (–8.49, 24.09)
bodily Pain 23.2 (17.4) 23.6 (17.7) 0.942 29.9 (16.8) 19.5 (18.1) 0.100 0.39 (–0.54, 13.81)
general Health 39.8 (16.1) 33.4 (12.1) 0.205 43.1 (11.0) 33.5 (11.4) 0.021* 0.24 (–5.28, 11.88)
Vitality 29.4 (15.3) 27.7 (17.5) 0.762 41.3 (13.8) 28.6 (18.8) 0.031* 0.82 (2.65, 21.22)
Social Function 55.2 (22.9) 48.6 (16.5) 0.313 63.9 (23.8) 52.2 (21.1) 0.142 0.37 (–5.47, 22.93)
role Emotional 53.3 (45.3) 45.6 (40.4) 0.608 71.1 (41.5) 52.1 (44.3) 0.216 0.41 (–16.62, 52.22)
Mental Health 51.3 (18.9) 44.0 (20.7) 0.304 60.0 (14.9) 44.2 (23.9) 0.034* 0.51 (1.20, 16.26)
bdI (0–63) 35.1 (14.1) 31.4 (12.8) 0.437 28.9 (13.6) 31.5 (11.2) 0.556 0.45 (–8.76, –3.64)
*p < 0.05. 
results reported as mean effect sizes (Cohen’s d) (95% confidence interval (95%)). 
CI: confidence interval.
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reach statistical significance. It is argued that a more prolonged 
strength training programme, such as that used in the current 
study, is necessary to achieve meaningful improvements in 
patients with FM. some weight is given to this argument by 
the findings of Panton et al. (37), who utilized a comparable 
strength training regime as kingsley et al. (35) (1 set of 8–12 
repetitions, starting at 60% of the one repetition maximum), 
over a period of 16 weeks, and reported a reduction in the 
FIQ in women with FM (Es between d = 0.98 and 1.24 using 
resistance training with or without chiropractic treatment). It is 
suggested that the findings from the current study lend further 
weight to the argument that exercise interventions (particularly 
strength training) should be more prolonged than that currently 
used in the clinical setting. 
several studies have used a combination of different exer-
cise therapies in FM and demonstrated improvements in the 
FIQ (9, 13, 14, 38). Even some short-term interventions have 
been demonstrated to be beneficial for this population (13, 14, 
38). However, the improvements reported tend to be smaller 
(d < 0.44) than those reflected in the present study and of limited 
duration. It is also worth noting that the overall health status 
of patients in the present study at baseline was worse in all 
dimensions than those reported by other authors (8). 
The current study investigated whether a combined exercise 
programme was as effective as usual care in the management 
of FM. The results suggest that there may be a synergistic 
benefit of conducting aerobic, strengthening and flexibility 
exercises together, and that a combined intervention is greater 
than the sum of its parts. There is some evidence to support 
this hypothesis from the exercise and cardiovascular health 
literature, where a number of authors have reported that 
the combination of resistance training and aerobic exercise 
yields greater improvements in the cardiovascular end-points 
of exercise performance, skeletal muscle function, and body 
composition, compared with aerobic training alone (39); this 
may also be the case in FM. 
People with FM have higher levels of depression than the 
general population and those with other chronic diseases, such 
as rheumatoid arthritis (40). some studies have suggested that 
combining different types of exercise programmes results in 
significant improvements in depression for patients with FM 
(10–12, 14, 15). It appears that long-term interventions resulted 
in improvements of 10–20% in depression (10, 25, 36); in the 
current study an improvement in depression scores of 18% was 
achieved; however, this did not reach statistical significance. 
Conversely, a significant medium effect improvement was 
noted in the mental health domain of the SF-36. 
The improvement in psychological status in those with FM 
may be related to the duration and intensity of the treatment 
programme; the longer the treatment, the better the results. In 
fact, correlations have been established between the amount 
of physical activity and bdI scores after a 12-month exercise 
programme (25). In this study, the exercise programme was 
conducted in groups; it may be that improvements in mental 
health resulted in part from the interaction between partici-
pants. However, even combined exercises performed at home 
involved significant benefit in terms of psychological well-
being, mood disturbance and somatic symptoms 12 month 
after completing a 12-week intervention based on aerobic 
home-exercises (9). 
The current study has two main limitations. First, the sample 
size may have resulted in a type II error, and may not have been 
sufficiently powered to detect between-group differences where 
they exist, while the study was powered to detect changes in 
the primary outcome measure this may not be the case for the 
other outcomes (such as the bdI). However, the findings also 
suggest that this novel treatment intervention is acceptable 
to patients and may have some beneficial effects. Neverthe-
less, further studies examining the effectiveness of combined 
exercise programmes should ensure they are appropriately 
powered to reduce the possibility of type II error. secondly, 
participants were assessed at the end of treatment only and 
no long-term follow-up was conducted, the long-term effects 
of the intervention are therefore unknown. Notwithstanding 
these limitations, it appears that patients with FM can tolerate 
an extended exercise intervention with no deterioration in the 
clinical presentation of the syndrome. From these results it may 
be concluded that a 24-week moderate intensity programme 
of aerobic exercise, muscle strengthening and flexibility ex-
ercises, twice a week, is effective for improving functional 
capacity and QoL in patients with FM, and that positive effects 
on psychological well-being can be expected. 
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